Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIRSEVIMAB vs NITROFURAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIRSEVIMAB vs NITROFURAZONE: Safety Overview

Metric NIRSEVIMAB NITROFURAZONE
Total FAERS Reports 247 307
Deaths Reported 5 298
Death Rate 2.0% 97.1%
Hospitalizations 149 87
Average Patient Age 0.3 yrs 44.0 yrs
% Female Patients 42.3% 99.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Sanofi Pasteur Inc. N/A
Route INTRAMUSCULAR N/A
Marketing Status N/A Discontinued